AWP
ABBV icon

Abacus Wealth Partners’s AbbVie ABBV Stock Holding History

Abacus Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Sell
8,029
-4,932
-38% -$1.06M 0.21% 34
2026
Q1 		$2.82M Buy
12,961
+171
+1% +$37.9K 0.26% 31
2025
Q4 		$2.92M Buy
12,790
+7,925
+163% +$1.81M 0.29% 28
2025
Q3 		$1.13M Buy
4,865
+204
+4% +$41.5K 0.16% 28
2025
Q2 		$865K Sell
4,661
-246
-5% -$45.7K 0.13% 34
2025
Q1 		$1.03M Buy
4,907
+3,302
+206% +$642K 0.15% 26
2024
Q4 		$285K Sell
1,605
-132
-8% -$24.3K 0.04% 67
2024
Q3 		$343K Buy
1,737
+225
+15% +$42K 0.05% 62
2024
Q2 		$259K Sell
1,512
-227
-13% -$37.6K 0.04% 67
2024
Q1 		$317K Buy
1,739
+329
+23% +$56.7K 0.05% 66
2023
Q4 		$219K Buy
+1,410
New +$206K 0.04% 71
2022
Q3 		– Sell
-2,287
Closed -$350K – 75
2022
Q2 		$350K Buy
2,287
+81
+4% +$12.4K 0.18% 48
2022
Q1 		$358K Sell
2,206
-107
-5% -$15.5K 0.16% 53
2021
Q4 		$313K Sell
2,313
-1,264
-35% -$149K 0.11% 74
2021
Q3 		$386K Buy
3,577
+250
+8% +$28.6K 0.14% 57
2021
Q2 		$375K Hold
3,327
– – 0.15% 56
2021
Q1 		$360K Buy
3,327
+975
+41% +$104K 0.26% 53
2020
Q4 		$252K Buy
+2,352
New +$226K 0.22% 71

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Abacus Wealth Partners's ABBV Position: Q2 2026 in Review

Abacus Wealth Partners reduced its AbbVie (ABBV) stake by 38% in Q2 2026, selling an estimated $1.06M and leaving 8,029 shares worth $2.02M. The position accounts for 0.21% of the portfolio, ranked #34.

Abacus Wealth Partners first reported a position in ABBV in Q4 2020 and has held it in 18 quarters since. The position peaked at $2.92M in Q4 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Abacus Wealth Partners held 8,029 shares of AbbVie worth $2.02M as of Q2 2026.
  • Abacus Wealth Partners sold 4,932 AbbVie shares in Q2 2026, an estimated $1.06M.
  • AbbVie made up 0.21% of Abacus Wealth Partners's portfolio in Q2 2026, its #34 holding.
  • Abacus Wealth Partners first reported a position in AbbVie in Q4 2020 and has held it in 18 quarters since.
  • Abacus Wealth Partners's AbbVie position peaked at $2.92M in Q4 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.